XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.850
0.00 (0.00%)
Aug 4, 2025, 4:00 PM - Market closed
Elevation Oncology Market Cap
XBiotech has a market cap or net worth of $86.89 million as of August 4, 2025. Its market cap has decreased by -56.64% in one year.
Market Cap
86.89M
Enterprise Value
-69.16M
1-Year Change
-56.64%
Ranking
Category
Stock Price
$2.85
Market Cap Chart
Since April 15, 2015, XBiotech's market cap has decreased from $737.40M to $86.89M, a decrease of -88.22%. That is a compound annual growth rate of -18.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 86.90M | -27.82% |
| Dec 31, 2024 | 120.40M | -1.07% |
| Dec 29, 2023 | 121.70M | 13.95% |
| Dec 30, 2022 | 106.80M | -68.43% |
| Dec 31, 2021 | 338.30M | -26.12% |
| Dec 31, 2020 | 457.90M | -40.29% |
| Dec 31, 2019 | 766.90M | 321.37% |
| Dec 31, 2018 | 182.00M | 30.37% |
| Dec 29, 2017 | 139.60M | -57.50% |
| Dec 30, 2016 | 328.50M | -6.09% |
| Dec 31, 2015 | 349.80M | -52.56% |
| Apr 15, 2015 | 737.40M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 683.69B |
| Johnson & Johnson | 407.90B |
| AbbVie | 345.47B |
| AstraZeneca | 228.08B |
| Abbott Laboratories | 225.27B |
| Novartis AG | 224.47B |
| UnitedHealth Group | 217.35B |
| Novo Nordisk | 211.90B |